Ramasamy K - Search Results

1

Fluorescence-based experimental model to evaluate the concomitant effect of drugs on the tumour microenvironment and cancer cells.

Ramasamy K, Khatun H, Macpherson L, Caley MP, Sturge J, Mufti GJ, Schey SA, Calle Y. Ramasamy K, et al. Br J Haematol. 2012 Jun;157(5):564-79. doi: 10.1111/j.1365-2141.2012.09103.x. Epub 2012 Mar 20. Br J Haematol. 2012. PMID: 22428569 Free article.

2

Successful treatment of refractory angioimmunoblastic T-cell lymphoma with thalidomide and dexamethasone.

Ramasamy K, Lim Z, Pagliuca A, Salisbury JR, Mufti GJ, Devereux S. Ramasamy K, et al. Haematologica. 2006 Aug;91(8 Suppl):ECR44. Haematologica. 2006. PMID: 16923528

3

Acute myeloid leukaemia presenting with mediastinal myeloid sarcoma: report of three cases and review of literature.

Ramasamy K, Lim Z, Pagliuca A, Devereux S, Ho AY, Mufti GJ. Ramasamy K, et al. Leuk Lymphoma. 2007 Feb;48(2):290-4. doi: 10.1080/10428190601059803. Leuk Lymphoma. 2007. PMID: 17325888

4

Successful pregnancies involving men with chronic myeloid leukaemia on imatinib therapy.

Ramasamy K, Hayden J, Lim Z, Mufti GJ, Ho AY. Ramasamy K, et al. Br J Haematol. 2007 May;137(4):374-5. doi: 10.1111/j.1365-2141.2007.06542.x. Epub 2007 Apr 4. Br J Haematol. 2007. PMID: 17408403 Free article. No abstract available.

5

The addition of cyclophosphamide to lenalidomide and dexamethasone in multiply relapsed/refractory myeloma patients; a phase I/II study.

Schey SA, Morgan GJ, Ramasamy K, Hazel B, Ladon D, Corderoy S, Jenner M, Phekoo K, Boyd K, Davies FE. Schey SA, et al. Among authors: ramasamy k. Br J Haematol. 2010 Aug;150(3):326-33. doi: 10.1111/j.1365-2141.2010.08250.x. Epub 2010 Jun 10. Br J Haematol. 2010. PMID: 20553268 Free article. Clinical Trial.

6

Mott cells in CD20-positive myeloma.

Ramasamy K, Ladon D, Salisbury J, Ireland R. Ramasamy K, et al. Br J Haematol. 2011 Feb;152(4):366. doi: 10.1111/j.1365-2141.2010.08508.x. Epub 2011 Jan 7. Br J Haematol. 2011. PMID: 21265822 Free article. No abstract available.

7

Pomalidomide therapy for myeloma.

Schey S, Ramasamy K. Schey S, et al. Among authors: ramasamy k. Expert Opin Investig Drugs. 2011 May;20(5):691-700. doi: 10.1517/13543784.2011.567265. Epub 2011 Mar 18. Expert Opin Investig Drugs. 2011. PMID: 21413906 Review.

8

Alemtuzumab-based reduced-intensity conditioning allogeneic transplantation for myeloma and plasma cell leukemia - a single-institution experience.

Ramasamy K, Mahmood S, Lim Z, Corderoy S, Devereux S, Mufti GJ, Pagliuca A, Schey S. Ramasamy K, et al. Clin Lymphoma Myeloma Leuk. 2011 Apr;11(2):242-5. doi: 10.1016/j.clml.2011.03.004. Epub 2011 Apr 8. Clin Lymphoma Myeloma Leuk. 2011. PMID: 21575930

9

Bendamustine in combination with thalidomide and dexamethasone is an effective therapy for myeloma patients with end stage renal disease.

Ramasamy K, Hazel B, Mahmood S, Corderoy S, Schey S. Ramasamy K, et al. Br J Haematol. 2011 Dec;155(5):632-4. doi: 10.1111/j.1365-2141.2011.08754.x. Epub 2011 Jun 21. Br J Haematol. 2011. PMID: 21689088 Free article. Clinical Trial. No abstract available.

10

Rituximab and thalidomide combination therapy for Castleman disease.

Ramasamy K, Gandhi S, Tenant-Flowers M, Ceesay M, Corderoy S, Marcus R, Schey S. Ramasamy K, et al. Br J Haematol. 2012 Aug;158(3):421-3. doi: 10.1111/j.1365-2141.2012.09157.x. Epub 2012 May 14. Br J Haematol. 2012. PMID: 22583139 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

561 results

Search Page